aprepitant oral / Generic mfg.  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
aprepitant oral / Generic mfg.
PATROL-II, UMIN000038644: A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant and olanzapine for highly emetogenic chemotherapy in breast cancer

Recruiting
2
89
Japan
Aloxi (palonosetron oral) - Helsinn, Otsuka, Roche, Eisai, Immedica, aprepitant oral - Generic mfg., olanzapine - Generic mfg.
Hoshi University; Division of Applied Pharmaceutical, University of Shizuoka, School of Pharmaceutical Sciences
Breast cancer;Oncology
 
 
APHOS 3, NCT06462287: EFFECT OF A SUBSTANCE P ANTAGONIST ON THE SECRETION OF ALDOSTERONE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME AND ARTERIAL HYPERTENSION

Recruiting
2
24
Europe
Aprepitant 125 and 80Mg Oral Capsule, Placebo
University Hospital, Rouen
Apnea, Obstructive
04/26
04/26
APRE-PONV, NCT06357234: Aprepitant Treatment to Prevent Postoperative Nausea and Vomiting in Children Undergoing Scoliosis Surgery

Not yet recruiting
2
100
NA
Aprepitant, Aprepitant oral suspension 20mg/ml, Placebo, Dextrose
IWK Health Centre
Spinal Fusion, Nausea and Vomiting, Postoperative, Anesthesia
03/26
04/26
NCT03683225: A Study to Evaluate in Patients With Parkinsonian Type Disorders

Active, not recruiting
2
24
US
CTC-413
Chase Therapeutics Corporation
Idiopathic Parkinson Disease
12/24
12/24

Download Options